Lymphoma Clinical Trials

A listing of Lymphoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Languages supported at study center
Age Group

Female only (1)
Any (59)

Phase 1 (16)
Phase 1/2 (9)
Phase 2 (18)
Phase 3 (5)
Unknown (12)

Interventional (53)
Observational (7)

Ruijin Hospital (4)
He Huang (3)
Memorial Sloan Kettering Cancer Center (3)
Shenzhen Geno-Immune Medical Institute (3)
The First Affiliated Hospital with Nanjing Medical University (3)
Beijing InnoCare Pharma Tech Co., Ltd. (2)
Henan Cancer Hospital (2)
M.D. Anderson Cancer Center (2)
Novartis Pharmaceuticals (2)
Second Affiliated Hospital, School of Medicine, Zhejiang University (2)
Affiliated Hospital to Academy of Military Medical Sciences (1)
Antengene Therapeutics Limited (1)
Baylor College of Medicine (1)
BeiGene (1)
Beijing Immunochina Medical Science & Technology Co., Ltd. (1)
Beijing Tongren Hospital (1)
Big Ten Cancer Research Consortium (1)
Celgene (1)
Chongqing Precision Biotech Co., Ltd (1)
Curon Biopharmaceutical (Australia) Co Pty Ltd (1)
Dana-Farber Cancer Institute (1)
Duke University (1)
Epizyme, Inc. (1)
Fate Therapeutics (1)
Fujian Medical University (1)
Fundamenta Therapeutics, Ltd. (1)
Hunan Cancer Hospital (1)
Institute of Hematology & Blood Diseases Hospital (1)
Loyola University (1)
Massachusetts General Hospital (1)
Medical University of Vienna (1)
Merck Sharp & Dohme LLC (1)
National Cancer Institute (NCI) (1)
Peking University (1)
Sanofi (1)
Scott R. Plotkin, MD, PhD (1)
Seattle Genetics, Inc. (1)
The First Affiliated Hospital of Soochow University (1)
The Lymphoma Academic Research Organisation (1)
University Hospital, Montpellier (1)
University of Colorado, Denver (1)
University of Zurich (1)
Wake Forest University Health Sciences (1)
Westlake Therapeutics (1)

No (60)

No (60)

All Languages (1)

Adult (18+) (60)
Pediatric (Under 18) (17)

I am/have/had

I am/have/hadlymphoma

I am/have/hadnon-hodgkin lymphoma

I am/have/hadhodgkin's disease

I am/have/hadcancer

I am/have/hadmeasurable disease

I am/have/hadcell transplantation

I am/have/hadarrhythmia

I am/have/hadhematologic malignancy

I am/have/hadhepatitis

I am/have/hadgraft versus host disease

I am/have/hadgilbert's syndrome

I am/have/hadleukemia

I am/have/hadb-cell lymphoma

I am/have/hadangina pectoris

I am/have/hadacute lymphoblastic leukemia

I am/have/hadfollicular lymphoma

I am/have/hadejection fraction

I am/have/hadlymphoid leukemia

I am/have/haddiffuse large b-cell lymphoma

I am/have/hadprimary cns lymphoma

added new label for I am/have/had

I am looking for

I am looking forrituximab

I am looking forendocrine therapy

I am looking forcyclophosphamide

I am looking formonoclonal antibodies

I am looking foretoposide

I am looking forfilgrastim

I am looking fordoxorubicin

I am looking forfludarabine

I am looking forprednisone

I am looking fornitrosoureas

I am looking formethotrexate

I am looking forcorticosteroids

I am looking forantineoplastic agents

I am looking forbortezomib

I am looking foribritumomab tiuxetan

I am looking fordexamethasone

I am looking fornivolumab

I am looking forhormone therapy

I am looking forimmunosuppressive agents

I am looking forbrentuximab vedotin

added new label for I am looking for

Advanced Filters

Found 17603 clinical trials

For pediatric ages
For Seniors
Recruiting in 100s
Observational Study
all
Hematology
Recruiting

Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma

lymphoma

0 views
16 Feb, 2024
1 location

For Seniors
For adults
Recruiting in 100s
Observational Study
all
Recruiting

Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies

EXALT-2 is a prospective, randomized, three arm study for treatment decision guided either by either comprehensive genomic profiling, next generation drug screening or physician's choice

basal cell carcinoma of the skin

cancer

melanoma of the skin

0 views
05 Aug, 2020

For Seniors
For adults
Recruiting in 100s
Observational Study
all
Family Medicine
Recruiting

Determination of Blood Tumor Cells

Magnetic nanoparticles coated with anti-EpCAM or anti-CD52 antibodies will be tested ex-vivo in patients blood .

cancer

lymphoma

leukemia

hematologic malignancy

0 views
16 Feb, 2024
1 location

1756
1757
1758
1759
1760
1761